A nuclease-resistant protein kinase C ribozyme blocks glioma cell growth

We investigated the cleavage activity, stability, and efficacy of 2'-amino pyrimidine modified ribozymes on malignant glioma growth. A synthetic protein kinase C (PKC) ribozyme with complete pyrimidine nucleotide substitution retained a comparable cleavage activity compared with the unmodified ribozyme. The half-life of the modified ribozyme in serum was increased 14,000-fold compared with the unmodified version. The PKC modified ribozyme inhibited glioma cell growth in vitro as a result of the inhibition of PKC gene expression. A single injection of cationic liposome ribozyme complexes into glioma tumors inhibited tumor growth, demonstrating both the efficacy of the ribozyme and a major role of PKC in tumor growth.

1. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., and Altman, S. 1983. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35: 849−847. | Article | PubMed  | ChemPort |
2. Cech, T. 1987. The chemistry of self-splicing RNA and RNA enzymes. Science 236: 1532−1539. | PubMed  | ISI | ChemPort |
3. Uhlenbeck, O.C. 1987. A small catalytic oligonucleotide. Nature 328: 596−619. | Article | PubMed  | ISI | ChemPort |
4. Haseloff, J. and Gerlach, W.L. 1988. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585−591. | Article | PubMed  | ISI | ChemPort |
5. Cameron, F.H. and Jennings, P.A. 1989. Specific gene suppression by engineered ribozymes in monkey cells. Proc. Natl. Acad. Sci. USA 83: 8859−8862.
6. Cotten, M. and Birnstiel, M.L. 1989. Ribozyme mediated destruction of RNA in vivo. EMBO J. 8: 3861−3866. | PubMed  | ISI | ChemPort |
7. Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A. et al. 1990. Ribozymes as potential anti HIV-1 therapeutic agents. Science 247: 1222−1225. | PubMed  | ISI | ChemPort |
8. Sioud, M. and Drlica, K. 1991. Prevention of HIV-1 integrase expression in E. coli by a ribozyme. Proc. Natl. Acad. Sci. USA 88: 7303−7307. | PubMed  | ChemPort |
9. Scanlon, K.J., Ishida, H., and Kashani-Sabet, M. 1994. Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc. Natl. Acad. Sci. USA 91: 11123−11127. | PubMed  | ChemPort |
10. Sioud, M. 1994. Interaction between tumor necrosis factor ribozyme and cellular proteins. J. Mol. Biol. 242: 619−629. | Article | PubMed  | ISI | ChemPort |
11. Chen, H., Ferbeyre, G., and Cedergren, R. 1997. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribozyme Escherichia coli mutant. Nature Biotechnology 15: 432−435. | Article | PubMed  | ISI | ChemPort |
12. Sioud, M. 1997. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates. Nucleic Acids Res. 25: 333−338. | Article | PubMed  | ISI | ChemPort |
13. Pieken, W.A., Olsen, D.B., Benseler, F., Aurup, H., and Eckstein, F. 1991. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science 253: 314−317. | PubMed  | ISI | ChemPort |
14. Williams, D.M., Pieken, W.A., and Eckstein, F. 1992. Function of specific 2'-hydroxyl groups of guanosines in a hammerhead ribozyme probed by 2' modifications. Proc. Natl. Acad. Sci. USA 89: 918−921. | PubMed  | ChemPort |
15. Heidenreich, O., Benseler, F., Fahrenholz, A., and Eckstein, F. 1994. High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates. J. Biol. Chem. 269: 2131−2138. | PubMed  | ISI | ChemPort |
16. Beigelman, L., McSwiggin, J.A., Draper, K.G., Gonzalez, C., Jensen, K., Karpeosky, A.M. et al. 1995. Chemical modification of hammerhead ribozymes. J. Biol. Chem. 270: 25702−25708. | Article | PubMed  | ISI | ChemPort |
17. Burgin, A.B., Conzalez, C., Matulic-Adamic, J., Karpeisky, A.M., Isman, N., McSwiggin, J.A. et al. 1996. Chemically modified hammerhead ribozymes with improved catalytic rates. Biochemistry 35: 14090−14097. | Article | PubMed  | ISI | ChemPort |
18. Scherr, M., Grez, M., Ganser, A., and Engels, J.W. 1997. Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. J. Biol. Chem. 272: 14304−14313. | Article | PubMed  | ISI | ChemPort |
19. Rossi, J.J. 1995. Controlled, targeted intracellular expression of ribozymes: Progress and problems. Trends Biotech. 13: 301−306. | Article | ISI | ChemPort |
20. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607−614. | PubMed  | ISI | ChemPort |
21. Couldwell, W.T., Uhm, J.H., Anterl, J.P., and Young, V.W. 1991. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29: 880−887. | Article | PubMed  | ISI | ChemPort |
22. Deen, F.D., Chiarodo, A., Grimm, E.A., Fike, J.R., Israel, M.A., Kun, L.E. et al. 1993. Brain tumor working group report on the 9th International Conference on Brain Tumor Research and Therapy. J. Neurooncol. 16: 243−272. | PubMed  |
23. Heidenreich, O., Pieken, W., and Eckstein, F. 1993. Chemically modified RNA. FASEB J. 7: 90−96. | PubMed  | ISI | ChemPort |
24. Nabel, G.J., Nabel, E.G., Zang, Z.Y., Fox, B.A., PLantz, G.E., Gao, X. et al. 1993. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90: 11307−11311. | PubMed  | ChemPort |
25. Mella, O., Bjerkvig, R., Schem, B.C., Dahl, O., and Laerum, O.D. 1990. A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BDIX rats. J. Neurooncology 9: 93−104. | ChemPort |
26. Saxena, S.K., and Ackerman, E.J. 1990. Ribozymes correctly cleave a model substrate and endogenous RNA in vivo. J. Biol Chem. 265: 17106−17109. | PubMed  | ISI | ChemPort |
27. Kroemer, G. 1997. The prot-oncogene Bcl-2 and its role in regulating apoptosis. Nat.Med. 3: 614−620. | ChemPort |
28. Aurup, H., Williams, D.M., and Eckstein, F. 1992. 2'-fluoro and 2'-amino-2'deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31: 9636−9641. | PubMed  | ISI | ChemPort |
29. Lee, S-W. and Sullenger, B.A. 1996. Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med. 184: 315−324. | Article | PubMed  | ISI | ChemPort |
30. Sioud, M. and Jespersen, L. 1996. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase. J. Mol. Biol. 257: 775−789. | Article | PubMed  | ISI | ChemPort |
31. Chomczynski, P., and Sacchi, N. 1987. Single step method of RNA Isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem. 162: 156−159. | Article | PubMed  | ISI | ChemPort |
32. Yoshitaka, O. 1988. Nucleotide sequences of cDNAs for and subspecies of rat brain protein kinase C. Nucl. Acids Res. 16: 5911−5912.
33. Sousa, R., and Padilla, R. 1995. A mutant T7 RNA polymerase as a DNA polymerase. EMBO J. 14: 4609−4621. | PubMed  | ISI | ChemPort |

	Top

	Top